-+ 0.00%
-+ 0.00%
-+ 0.00%

Davide Campari-Milano Shares Rose Even As Profit Fell

Simply Wall St·11/07/2026 19:22:44
Listen to the news

If you only glanced at Davide Campari-Milano’s recent headlines about softer organic growth, tariff pressure and a thinner net margin, you might not expect a strong result for anyone who simply held on. For Davide Campari-Milano shareholders, the return from the start of the year was 22.3%, including dividends. If you had been deciding on 1 January whether to buy, what did the clash between bullish expansion hopes and bearish consumption worries really signal?

A Narrative on Simply Wall St is one investor's written case for a company, with its growth, margin and multiple assumptions spelled out. Those assumptions imply an estimated Fair Value.

If the move has made Davide Campari-Milano harder to judge, start where the gap is still open and scan 224 high quality undervalued stocks.

The Two Davide Campari-Milano Stories Investors Had To Choose Between

The shares cost €5.53 at the start of the period, and anyone weighing Davide Campari-Milano then faced two very different but credible stories about where value might sit.

The bullish narrative put fair value at €6.75, which was 22% above the start price. It rested on Davide Campari-Milano using global expansion, premiumisation and capacity investment to support earnings, while still accepting risks from tariffs and currency shifts that could pressure margins.

The bearish view set fair value at €4.20, or 24% below the start price. That scenario leaned on long term declines in alcohol consumption and higher regulatory and input costs, which could restrict demand and compress profitability for Campari’s core brands.

BIT:CPR Trailing 12-Month Earnings & Revenue History as at Nov 2026
BIT:CPR Trailing 12-Month Earnings & Revenue History as at Nov 2026

What The Results Changed For Davide Campari-Milano

Q1 2026 organic sales growth of 2.9% at Davide Campari-Milano, with full-year guidance for about 3% and broad-based gains, gave the optimistic expansion story some support. The same period also brought softer conditions. H1 2026 revenue slipped to €1,512m and net income to €129m, with net margin narrowing to 8.5%. The evidence cut both ways.

The hinge assumption here was margin resilience. For any other stock, you would want to test upbeat growth stories against reported net margin and absolute profit rather than only watching top-line guidance.

What Davide Campari-Milano’s Price Already Assumes

Davide Campari-Milano now trades at €6.64, with this Narrative’s Fair Value sitting below that level and implying the recent gain from the start of the year already prices in a lot of good news.

The Narrative hinges on cost efficiency, portfolio pruning and developing-market growth offsetting mix issues, higher logistics and insurance expenses and pressure in Germany. A buyer today would be assuming that these efficiency plans and new Aperol formats translate into durable margins despite rising operating costs.

"The current valuation implies the share price already reflects continued organic growth, margin accretion and developing-market expansion, which leaves limited room for disappointment if category, tariff or cost risks affect earnings."

One Narrative has put a figure on that disagreement. → See the Narrative with its lower Fair Value, assumptions and all

Find Your Own Contrarian Opportunity

The story behind this run has already been told. The next one could be taking shape somewhere else. Where could you start looking before it becomes the headline?

  • Company 1 - 22% below our estimate - expands its sales force to pursue more maintenance contracts and renewals.
  • Company 2 - 48% below our estimate - pushes existing customers toward higher-tier licenses that increase recurring software fees.
  • Company 3 - 30% below our estimate - runs a large gold reserve base while managing extraction costs and political risk.

That is three of the list. See all 193 companies with the balance sheet to back it up →